no news_id given

Miscellaneous

23.11.2009

Reykjavik - Decode Genetics, a pioneering Icelandic biotechnology company, has filed for bankruptcy. The firm has been experiencing serious financial trouble since autumn last year when it informed investors of insufficient funds...

BioFunding

17.11.2009

Europe’s ambitious pilot biobanking project, the BBMRI (Biobanking and Bio­molecular Resources Research Infrastructure) has attracted massive investment from national biobanking initiatives. The project is to link up to 300...

Tech Review

16.11.2009

The biopharmaceutical industry has seen plenty of change over the past 20 years, with the yield of recombinant proteins increasing from tens of milligrams to more than 10 grams per liter for some monoclonal antibodies in early...

Tech Review

16.11.2009

Only a year after bioprocessing world market leader Millipore Corp. entered into a partnership with Dutch stainless steel bioreactor specialist Applikon Biotechnology BV, the companies have rolled out a major project – the...

Politics / Law

16.11.2009

Shipments of soybeans from the US are unlikely to return to normal anytime soon, even though in November the European Commission expanded the range of transgenic species that may enter the bloc. “It‘s highly unlikely that imports...

Politics / Law

16.11.2009

Brussels – European Commission President Jose Manuel Barroso is planning to appoint a chief scientific adviser to combine the process of political decision-making with scientific advice in fields like GMOs, synthetic biology, and...

Miscellaneous

16.11.2009

Brussels/New York – China’s annual research output exploded in the past decade, soaring from 20,000 publications in 1998 to 112,000 a decade later. It has now outpaced the EU and Japan, and is set to overtake the US within the...

Politics / Law

16.11.2009

Brussels/Strasbourg – The pharmaceutical industry has agreed to accept a review of direct-to-consumer information on prescription medicines prior to its publication on the Internet or in newspapers. According to Euractiv, EFPIA...

Politics / Law

15.11.2009

Brussels – In the run-up to the presentation of the European Commission’s new European Innovation Act next spring, the SME interest group at Business-Europe has begun lobbying for lower taxes, financial aid and a set of common IP...

BioFunding

15.11.2009

Brussels – The Innovative Medicines Initiative (IMI) has published its second call for funding. “By accelerating and optimising R&D processes, we are trying to remove bottlenecks in the drug development process,” explained Arthur...

Displaying results 371 to 380 out of 1983

< Previous 371-380 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/news/messages-archive/archive/browse/37.html

Image Gallery

Stock list

All quotes

TOP

  • MORPHOSYS (D)62.00 EUR11.8%
  • BIOINVENT INTERNATIONAL AB (S)2.96 SEK10.9%
  • BAVARIAN NORDIC (D)14.56 EUR10.3%

FLOP

  • CYTOS (CH)0.17 CHF-26.1%
  • XENETIC BIOSCIENCES (UK)6.00 GBP-14.3%
  • FLAMEL TECHNOLOGIES (F)9.94 USD-9.7%

TOP

  • CO.DON (D)3.30 EUR90.8%
  • BIOTECH PHARMACON (N)17.50 NOK63.6%
  • WILEX (D)0.92 EUR55.9%

FLOP

  • CYTOS (CH)0.17 CHF-94.0%
  • BIONOR PHARMA (N)2.11 NOK-48.0%
  • GW PHARMACEUTICALS (UK)219.25 GBP-39.8%

TOP

  • SILENCE THERAPEUTICS (UK)256.00 GBP6221.0%
  • IXICO (UK)71.50 GBP791.5%
  • PLETHORA (UK)10.62 GBP585.2%

FLOP

  • CYTOS (CH)0.17 CHF-95.8%
  • EVOCUTIS (UK)0.22 GBP-92.5%
  • AGENNIX (D)0.04 EUR-77.8%

No liability assumed, Date: 17.04.2014

Current issue

All issues

Product of the week

Products

Events

All Events

Partner-Events

München

BioVaria 2014

Frankfurt am Main

7th DVFA Life Science Conference

White Paper